Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Transplantation

• Publication date

  1998-12-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199812270-00035PMID 9884275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon-gamma in a family with X-linked lymphoproliferative syndrome with acute Epstein-Barr virus infection

  2004cited by this paper
• Reversible renal failure in a patient with the hypereosinophilia syndrome during therapy with alpha interferon.

  1998cited by this paper
• Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.

  1998cited by this paper
• Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.

  1998cited by this paper
• Infection in organ-transplant recipients.

  1998cited by this paper
• Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease.

  1997cited by this paper
• Epstein-Barr virus lymphoproliferative disorder in children with leukemia: case report and review of the literature.

  1997cited by this paper
• Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients.

  1997cited by this paper
• Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.

  1997cited by this paper
• Acute renal failure and nephrotic syndrome with alpha interferon therapy.

  1997cited by this paper
• Modulation of interleukin-6/interleukin-6 receptor cytokine loop in the treatment of multiple myeloma.

  1997cited by this paper
• INTERFERONS IN ONCOLOGY

  1997cited by this paper
• Prognostic Value of Serum Interleukin-6 in Diffuse Large-cell Lymphoma

  1997cited by this paper
• Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient.

  1996cited by this paper
• Long-term interferon-alpha therapy induces autoantibodies against epidermis.

  1996cited by this paper
• Therapeutic potential of humanized anti-interleukin-6 receptor antibody: antitumor activity in xenograft model of multiple myeloma.

  1996cited by this paper
• Oral presentation of posttransplantation lymphoproliferative disorders. An unusual manifestation.

  1996cited by this paper
• Posttransplant T-cell lymphoproliferative disorders--an aggressive, late complication of solid-organ transplantation.

  1996cited by this paper
• Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia.

  1996cited by this paper
• Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease.

  1996cited by this paper
• Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.

  1996cited by this paper
• Switching viral latency to viral lysis: a novel therapeutic approach for Epstein-Barr virus-associated neoplasia.

  1996cited by this paper
• Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

  1996cited by this paper
• Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.

  1996cited by this paper
• Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C.

  1996cited by this paper
• Successful treatment of posttransplant lymphoproliferative disorder with renal graft preservation by monoclonal antibody therapy.

  1996cited by this paper
• Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.

  1995cited by this paper
• Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.

  1995cited by this paper
• Successful treatment of Epstein-Barr virus infection with ganciclovir and cytomegalovirus hyperimmune globulin following kidney transplantation.

  1995cited by this paper
• Interferon-induced acute renal failure: a case report and literature review

  1995cited by this paper
• Pretransplantation assessment of the risk of lymphoproliferative disorder.

  1995cited by this paper
• Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.

  1995cited by this paper
• INTERFERON-α-INDUCED ACUTE RENAL ALLOGRAFT REJECTION

  1995cited by this paper
• Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response?

  1995cited by this paper
• Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring.

  1995cited by this paper
• Early identification of Epstein‐Barr virus‐associated post‐transplantation lymphoproliferative disease

  1995cited by this paper
• Interferon-alpha-induced acute renal allograft rejection.

  1995cited by this paper
• Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma.

  1995cited by this paper
• Post-transplant B-cell lymphomas--correlation of late stage B-cell differentiation and progression of disease; treatment with chimeric monoclonal antibody.

  1995cited by this paper
• Minimal change glomerulonephritis with reversible proteinuria during interferon α2a therapy for chronic myeloid leukemia

  1995cited by this paper
• Aggressive treatment for postcardiac transplant lymphoproliferation.

  1995cited by this paper
• Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin.

  1995cited by this paper
• Lymphoproliferative disease after pediatric liver transplantation.

  1994cited by this paper
• Clinical characteristics of post-transplant lymphoproliferative disorders.

  1994cited by this paper
• Membranoproliferative glomerulonephritis in a patient treated with interferon-alpha for human immunodeficiency virus infection.

  1994cited by this paper
• Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate.

  1994cited by this paper
• Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.

  1994cited by this paper
• Minimal-change glomerulopathy and glomerular visceral epithelial hyperplasia associated with alpha-interferon therapy for cutaneous T-cell lymphoma.

  1994cited by this paper
• Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study.

  1994cited by this paper
• POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RENAL ALLOGRAFT RECIPIENTS: CLINICAL EXPERIENCE AND RISK FACTOR ANALYSIS IN A SINGLE CENTER

  1993cited by this paper
• Effects of an anti-interleuktn-6 (IL-6) murine monoclonal antibody in a patient with acute monoblastic leukemia

  1993cited by this paper
• EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.

  1993cited by this paper
• Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.

  1993cited by this paper
• Description of an In Situ Hybridization Methodology for Detection of Epstein‐Barr Virus RNA in Paraffin‐Embedded Tissues, with a Survey of Normal and Neoplastic Tissues

  1992cited by this paper
• Unusual glomerular lesion in a patient receiving long-term interferon alpha.

  1992cited by this paper
• Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.

  1992cited by this paper
• [Lymphoproliferative syndromes associated with Epstein-Barr virus in transplantation].

  1992cited by this paper
• Lymphoproliferative disorder early after cardiac transplantation.

  1991cited by this paper
• Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant lymphoproliferative disorder?

  1991cited by this paper
• Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation.

  1991cited by this paper
• Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

  1991cited by this paper
• Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients.

  1991cited by this paper
• Epstein‐Barr Virus Lymphoproliferative Disease Associated with Acquired Immunodeficiency

  1991cited by this paper
• Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.

  1991cited by this paper
• Renal retransplantation in patients who lost their allografts during management of previous post‐transplant lymphoproliferative disease

  1990cited by this paper
• Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals.

  1990cited by this paper
• Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.

  1990cited by this paper
• Interferons.

  1989cited by this paper
• Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation.

  1989cited by this paper
• Epstein-Barr virus associated lymphoproliferative diseases (B cell lymphoma) after transplantation.

  1989cited by this paper
• The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

  1988cited by this paper
• ADVERSE EFFECT OF LOW‐DOSE PROPHYLACTIC HUMAN RECOMBINANT LEUKOCYTE INTERFERON‐ALPHA TREATMENT IN RENAL TRANSPLANT RECIPIENTS: Cytomegalovirus Infection Prophylaxis Leading to an Increased Incidence of Irreversible Rejections

  1988cited by this paper
• Treatment of Severe Epstein-Barr Virus-Induced Polyclonal B-Lymphocyte Proliferation by Anti-B-Cell Monoclonal Antibodies: Two Cases After HLA-Mismatched Bone Marrow Transplantation

  1988cited by this paper
• The diagnosis and treatment of posttransplant lymphoproliferative disorders.

  1988cited by this paper
• Treatment of severe Epstein-Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Two cases after HLA-mismatched bone marrow transplantation.

  1988cited by this paper
• Abnormal T-cell subsets in normal persons.

  1988cited by this paper
• Renal transplant obstruction by B cell lymphoproliferative disorder: case report and review of the literature.

  1988cited by this paper
• Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin.

  1988cited by this paper
• Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation.

  1988cited by this paper
• Membranoproliferative glomerulonephritis in a patient with hairy-cell leukemia treated with alpha-II interferon.

  1987cited by this paper
• Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.

  1986cited by this paper
• Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia. Therapeutic and immunologic results.

  1986cited by this paper
• Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.

  1986cited by this paper
• Nephrotic syndrome during treatment with interferon.

  1985cited by this paper
• Alpha interferon for induction of remission in hairy-cell leukemia.

  1984cited by this paper
• Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues.

  1984cited by this paper
• Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

  1984cited by this paper
• Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides.

  1984cited by this paper
• Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients.

  1983cited by this paper
• Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma.

  1983cited by this paper
• Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

  1983cited by this paper
• A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients.

  1982cited by this paper
• Identification of T-lymphocytes and T-subsets in human tonsil using monoclonal antibodies and the immunoperoxidase technic.

  1981cited by this paper
• Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections.

  1979cited by this paper
• Letter: Myopathies: the neurogenic hypothesis.

  1974cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper

• Management of PTLD after SOT

  2021cites this paper
• Relationship between rabbit anti-thymocyte globulin and development of PTLD and its aggressive form in renal transplant population

  2020cites this paper
• Post Transplant Lymphoproliferative Disorder

  2019cites this paper
• Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder

  2018cites this paper
• Post-transplant lymphoproliferative disorders

  2016cites this paper
• Lymphoma in Danon disease with chronic rhabdomyolysis treated with EPOCH-R

  2016cites this paper
• A Case Report of NK-Cell Lymphoproliferative Disease With a Wide Involvement of Digestive Tract Develop Into Epstein–Barr Virus Associated NK/T Cell Lymphoma in an Immunocompetent Patient

  2016cites this paper
• Post-transplant lymphoproliferative disorders.

  2015cites this paper
• Pan-viral-microRNA screening identifies interferon inhibition as a common function of diverse viruses

  2015cites this paper
• Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.

  2014cites this paper
• Small Intestinal Lymphoma in a Post-Renal Transplant Patient: A Rare Case with Late Presentation

  2014cites this paper
• Comparative analysis of post‐transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation

  2014cites this paper
• 96. Post-Transplant Lymphoproliferative Disorders

  2014cites this paper
• Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies

  2013cites this paper
• Treatment of Epstein–Barr Virus Infections: Chemotherapy, Antiviral Therapy, and Immunotherapy

  2013cites this paper
• Management of oncologic transplant recipient: the profile of the radiation oncologist.

  2013cites this paper
• Molecular Pathogenesis of B-Cell Posttransplant Lymphoproliferative Disorder: What Do We Know So Far?

  2013cites this paper
• Post Transplant Lymphoproliferative Disorders: Risk, Classification, and Therapeutic Recommendations

  2012cites this paper
• Post-Transplant Lymphoproliferative Disease – PTLD

  2012cites this paper
• Posttransplant lymphoproliferative disorder presenting as a nonhealing extraction socket: a case report and review of the literature.

  2012cites this paper
• Post‐Transplant Lymphoproliferative Disorder and other Malignancies after Liver Transplantation

  2012cites this paper
• 4 Posttransplant Lymphoproliferative Disorders Following Kidney Transplantation

  2012cites this paper
• Post Transplant Lymphoproliferative Disorders After Liver Transplantation

  2012cites this paper
• Emerging therapeutic strategies for Epstein–Barr virus+ post‐transplant lymphoproliferative disorder

  2012cites this paper
• Post-transplantation lymphoproliferative disorder (PTLD) twenty years after heart transplantation: a case report and review of the literature

  2011cites this paper
• Radiotherapy is the best treatment method in post transplant lymphoproliferative disorders localizing in brain: a review of the literature.

  2011cites this paper
• Lymphoproliferative Disorders After Solid Organ Transplantation—Classification, Incidence, Risk Factors, Early Detection and Treatment Options

  2011cites this paper
• Posttransplant Lymphoproliferative Disease in Liver Transplant Patients

  2011cites this paper
• Posttransplant Lymphoproliferative Disorders Following Kidney Transplantation

  2011cites this paper
• Therapeutic options in post-transplant lymphoproliferative disorders

  2011cites this paper
• Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update

  2011cites this paper
• Management of post‐transplant lymphoproliferative disorder in adult solid organ transplant recipients – BCSH and BTS Guidelines

  2010cites this paper
• Post-Transplantation Lymphoproliferative Disorders: Diagnosis, Prognosis, and Current Approaches to Therapy

  2010cites this paper
• Posttransplant lymphoproliferative disorder following kidney transplant.

  2010cites this paper
• Treatment of PTLD

  2010cites this paper
• PTLD treatment: Reducing the chemotherapy burden through addition of rituximab

  2010cites this paper
• Post‐transplant lymphoproliferative disorder in children: Recent outcomes and response to dual rituximab/low‐dose chemotherapy combination

  2010cites this paper
• The changing face of post‐transplant lymphoproliferative disease in the era of molecular EBV monitoring

  2010cites this paper
• EBV-associated post-transplantation B-cell lymphoproliferative disorder following allogenic stem cell transplantation for acute lymphoblastic leukaemia: tumor regression after reduction of immunosuppression - a case report

  2010cites this paper
• Lymphoma: risk and response after solid organ transplant.

  2010cites this paper
• IN PRACTICE Posttransplant Lymphoproliferative Disorder Following Kidney Transplant

  2010cites this paper
• New Possibilities to Improve the Outcomes of Renal Transplantation

  2009cites this paper
• PTLD treatment: Reducing the chemotherapy burden through addition of rituximab: Editorial

  2009cites this paper
• Epstein-Barr Virus Infection and Primary Central Nervous System Lymphoma

  2009cites this paper
• Infectious Diseases in Pediatric Cancer

  2009cites this paper
• Élaboration d'un anticorps chimère anti-gp350 comme traitement prophylactique éventuel des syndromes lymphoprolifératifs B chez les greffés

  2009cites this paper
• Post-transplant lymphoproliferative disorder.

  2009cites this paper
• Malignancy after solid organ transplantation: an overview.

  2008cites this paper
• Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha-2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder

  2008cites this paper
• Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series.

  2007cites this paper
• Late occurrence of malignant post‐transplant lymphoproliferative disorder (PTLD) presenting with severe acute renal failure

  2007cites this paper
• The management of posttransplant lymphoproliferative disorder

  2007cites this paper
• Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice.

  2007cites this paper
• Complete regression of cutaneous B-cell lymphoma in a renal transplant patient after conversion from cyclosporin to sirolimus.

  2007cites this paper
• Adoptive immunotherapy for Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease

  2007cites this paper
• CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.

  2007cites this paper
• Transplantation: Posttransplant Lymphoproliferative Disorder

  2007cites this paper
• Lymphoproliferative Disorders Related to Immunodeficiencies

  2007cites this paper
• Management of patients with post‐transplant lymphoproliferative disorder: the role of rituximab

  2006cites this paper
• Review of Epstein–Barr virus and post‐transplant lymphoproliferative disorder post‐solid organ transplantation (Review Article)

  2006cites this paper
• Post-transplant lymphoproliferative disorders.

  2006cites this paper
• Long‐term survival in post‐transplant lymphoproliferative disorders with a dose‐adjusted ACVBP regimen

  2006cites this paper
• Posttransplant lymphoproliferative disorder of the lung in a renal transplant recipient treated successfully with surgery.

  2006cites this paper
• Pathogenetic, Clinical, Diagnostic, and Therapeutic Aspects of Post-Transplantation Lymphoproliferative Disorders

  2006cites this paper
• What is the current treatment of PTLD after liver transplantation?

  2006cites this paper
• Critical Care Perspective on Immunotherapy in Lung Transplantation

  2006cites this paper
• [Lymphoproliferative disease following kidney transplantation].

  2005cites this paper
• Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.

  2005cites this paper
• Treatment of EBV‐Related Post‐Renal Transplant Lymphoproliferative Disease with a Tailored Regimen Including EBV‐Specific T Cells

  2005cites this paper
• Mini‐BEAM and autologous hematopoietic stem‐cell transplant for treatment of post‐transplant lymphoproliferative disorders

  2005cites this paper
• Post-transplant lymphoproliferative disorder.

  2005cites this paper
• Posttransplant Lymphoproliferative Disorder in Pancreas Transplantation: A Single-Center Experience

  2005cites this paper
• Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.

  2005cites this paper
• Post-transplant lymphoproliferative disorders.

  2005cites this paper
• Lymphoproliferative disease after lung and heart-lung transplantation: first description in Spain.

  2005cites this paper
• Posttransplant lymphoproliferative disease.

  2005cites this paper
• Lymphoproliferative Erkrankungen nach Nierentransplantation

  2005cites this paper
• Lymphoproliferative disorders after liver transplantation.

  2004cites this paper
• Posttransplant lymphoproliferative disorder resembling a chronic orocutaneous infection in an immunosuppressed patient.

  2004cites this paper
• Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients.

  2004cites this paper
• Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.

  2004cites this paper
• Transplantation of the Pancreas

  2004cites this paper
• Tratamiento de los síndromes linfoproliferativos postrasplante

  2003cites this paper
• Anti-CD20 monoclonal antibody treatment of Epstein-Barr virus-induced intrahepatic lymphoproliferative disorder following liver transplantation

  2003cites this paper
• Viral infections in renal transplantation - newer herpes viruses, polyoma BK virus, EBV related posttransplantation lymphoproliferative disorder Zakażenia wirusowe w przeszczepach nerek - nowe wirusy herpes, wirus BK polyoma, EBV oraz potransplantacyjny zespół limfoproliferacyjny

  2003cites this paper
• CNS Post-Transplant Lymphoproliferative Disorder

  2003cites this paper
• Adoptive T-Cell Therapy for EBV-Associated Post-Transplant Lymphoproliferative Disease

  2003cites this paper
• Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants: a review

  2003cites this paper
• Epstein-Barr Virus: Pathogenesis and Treatment

  2003cites this paper
• T cell immunodeficiency and severe herpes virus infections after allogeneic stem cell transplantation

  2003cites this paper
• A pilot study of chemoimmunotherapy (cyclophosphamide, prednisone, and rituximab) in patients with post-transplant lymphoproliferative disorder following solid organ transplantation.

  2003cites this paper
• Immunotherapy for Epstein-Barr virus-associated cancers in children.

  2003cites this paper
• 2001 Canadian Cardiovascular Society Consensus Conference on cardiac transplantation.

  2003cites this paper
• Post-transplant lymphoproliferative disorder: a review

  2003cites this paper
• [Management of lymphoproliferative disorders associated to organ transplantation].

  2003cites this paper
• Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.

  2003cites this paper
• Anti‐CD20 monoclonal antibody treatment of Epstein‐Barr virus‐induced intrahepatic lymphoproliferative disorder following liver transplantation

  2003cites this paper
• Tailored Chemotherapy for Malignant Lymphoma Arising in the Setting of Posttransplant Lymphoproliferative Disorder After Solid Organ Transplantation

  2002cites this paper
• Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management.

  2002cites this paper
• Post-transplant lymphoproliferative disorders: making sense of the proliferation of potential therapies.

  2002cites this paper